FDA Inspection
Mylan Laboratories LimitedMylan Laboratories Limited – FDA Inspection, Jun 26, 2024
Record Details
This FDA Inspection record concerns Mylan Laboratories Limited, with an inspection on June 26, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 0b1a52d0-6f3f-4feb-8cbe-27eb0ea62055
Inspection Facts
- Inspection number
- 1242111
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.103Actual vs. theoretical yields not determined
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mylan Laboratories Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 24, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 14, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Mylan Laboratories Limited
- FDA Inspection 1095599 - 2019-05-24
- FDA Inspection 960871 - 2016-02-05
- FDA Inspection 870220 - 2014-03-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.